Belgium
R&D Project Manager and Life Sciences Professional with 9 years of combined experience across global FMCG, clinical research, and pharmaceutical environments. Currently leads end-to-end R&D execution for a $2B P&G Air Care brand across 8 European markets and contributes into making Air Care the fastest-growing franchise in Home Care Europe. Brings a rigorous Quality Assurance foundation and AI-augmented execution approach — embedding CAPA, deviation management, and compliance checkpoints into stage-gate delivery to safeguard product integrity, accelerate timelines, and sharpen decision-making.
P&G Fabric & Home Care — $28B+ FY2024 sales, ~35% global market share, P&G’s largest division; six consecutive years of 4%+ organic growth. – Sustained P&G EU Air Care’s #1 value share position to 19.3% across 8 markets — contributing to 2.8× growth vs. fair share, a 5th consecutive year of NOS growth, and making Air Care the #1 contributor to category growth and fastest-growing franchise in Home Care Europe. – Converted quality signals into preventive action by leading the EMEIA Consumer Complaints programme — coordinating root cause analyses, driving CAPA implementation to closure, and reducing recurrence of consumer-facing issues across multiple markets. – Safeguarded regulatory standing and launch readiness as the embedded quality gatekeeper within R&D stage-gates — identifying and resolving formulation, safety, and compliance risks before commercialisation. – Embedded GMP-aligned standards into daily operations — building an audit-ready workforce and ensuring lab compliance by mentoring R&D technicians. – Deployed AI tools (ChatGPT, Copilot, internal P&G platforms) to cut manual processing time across the EMEIA complaints workflow — freeing analyst capacity for higher-value investigation. – Turned consumer feedback and product performance data into actionable business intelligence through JMP Pro, Python, and Power BI AI dashboards.
– Built the quality-assured experimental foundation for P&G EU Air Care’s innovation pipeline — delivering reproducible, audit-ready studies enabling regulatory sign-off and commercialisation decisions across multiple active projects. – Protected launch timelines across a multi-market pipeline by orchestrating alignment between formulation, safety, and regulatory stakeholders within stage-gate frameworks. – Raised the quality floor of the R&D lab by co-authoring SOPs and driving process improvements — eliminating rework and positioning the lab for stronger audit performance.
– Supported fragrance prototype development and evaluation within a regulated R&D environment, maintaining documentation and raw material control standards.